1.      Backes CH, Rivera BK, Bridge JA, et al. Percutaneous patent ductus arteriosus closure during infancy: a meta-analysis. J Pediatr. 2017;181:45–51.e4.

2.      Benitz WE. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137(1):e20153730.

3.      Clyman RI. Mechanisms regulating the ductus arteriosus. Semin Perinatol. 2018;42(4):273–280.

4.      Czernik C, Metze B, Müller C, et al. B-type natriuretic peptide for the diagnosis of patent ductus arteriosus in preterm infants. Pediatrics. 2008;122(4):e747–e752.

5.      de Boode WP, Kluckow M, McNamara PJ, et al. Hemodynamic assessment of the patent ductus arteriosus: beyond ultrasound. Pediatr Res. 2018;84(Suppl 1):46–52.

6.      de Winter JP, van der Lugt NM, Smits‐Wintjens VEHJ, et al. Early treatment versus expectant management of patent ductus arteriosus in preterm infants (BeNeDuctus Trial). Neonatology. 2022;119(6):701–710.

7.      El-Khuffash A, Jain A, McNamara PJ. Biomarkers and hemodynamically significant patent ductus arteriosus. J Pediatr. 2017;180:15–21.

8.      Evans N. Functional echocardiography in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2011;96(3):F161–F165.

9.      Hammerman C, Kaplan M. Prostaglandins and the ductus arteriosus. Neonatology. 2019;115(2):150–157.

10.  Hamrick SEG, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125(5):1020–1030.

11.  Hundscheid T, Onland W, van Overmeire B, et al. Early treatment versus expectant management of patent ductus arteriosus and neurodevelopmental outcome. J Pediatr. 2018;203:45–50.e2.

12.  Kluckow M, Evans N. Low systemic blood flow and pathophysiology of the preterm transitional circulation. J Pediatr. 2000;136(2):165–172.

13.  McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Semin Fetal Neonatal Med. 2007;12(5):353–359.

14.  Mitra S, Florez ID, Tamayo ME, et al. Association of early versus delayed treatment of patent ductus arteriosus with neonatal outcomes. Pediatrics. 2018;142(2):e20180765.

15.  Ohlsson A, Shah SS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev. 2020;(1):CD010061.

16.  Sathanandam S, Balduf K, Chilakala S, et al. Amplatzer Piccolo Occluder clinical trial: transcatheter closure of patent ductus arteriosus in extremely low birth weight infants. J Am Coll Cardiol. 2020;76(20):2345–2354.

17.  Sung SI, Chang YS, Chun JY, et al. Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. Neonatology. 2016;109(3):178–185.